Global Biosimilars Market was currently valued at $5237.0 and is projected to grow at CAGR of 40.3% during the forecast period, reaching $28200.0 million by 2020 :Top keyplayers are Sandoz, Dr. Reddys, Accord Healthcare

Kenneth research - Monday, February 11, 2019.
Enviado por Research Nester


Biosimilar is a biological product, which is an identical copy of the original product and is expected to possess properties similar to the older, previously licensed version. These biosimilars can be made only when the patent for the original product expires.


Request For Free Sample@  

Market Dynamics

The Global Biosimilars Market was currently valued at $5237.0 and is projected to grow at CAGR of 40.3% during the forecast period, reaching $28200.0 million by 2020.
The factors that are fuelling the growth of this market include increasing need for cost-effective drugs, increasing number of patents expiring in the near future accounting for approximate sales of $9.1 billion, intended reductions in the healthcare expenditure and cost-effectiveness of biosimilar drugs. Other than these, the increasing demand for biosimilars is another driving force for this market.

However, there are some factors that restrain the growth of this market, such as different regulatory frameworks in different countries, high manufacturing complexities and varying technologies. Also there are complexities related to scaling up of operations.

Market Segmentation

Global biosimilars market can be segmented as follows :
Segmentation by application includes - Chronic and autoimmune diseases, Blood disorders, Growth hormone deficiency diseases and Oncology. The blood disorders segment dominates the market accounting for more than 55% of the share.

Segmentation by end user involves Retail pharmacies and Hospitals. The retail pharmacies segment lead the global biosimilars market with 52% market share.

Regional/Geographic Analysis

In terms of geography, EMEA was the region contributing with the highest revenue in the global biosimilars market and is expected to reach to approx.. $5 billion by 2020. The market will witness high growth in countries such as the France, Spain, UK, Germany and Italy. The biosimilars market in UK is mature and well-established, making the generic drugs market more stronger. The growth in this area is attributed to well-defined regulatory frameworks.


Buy Now@  

Key Players

The major players in the global biosimilars market are Sandoz, Dr. Reddys, Accord Healthcare, Apotex, Teva Pharmaceuticals, Hospira, Bioton, Eli Lilly, Biocon, Sun-Ranbaxy, Zydus Cadila, Hexal, Synthon, and Celltrion.

Report Contents Regional Analysis Report Highlights

Market segments
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market - Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada

Latin America
Mexico, Brazil, Argentina and Rest of Latin America

Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe

Eastern Europe
Rest of Eastern Europe

Asia Pacific
Australia and New Zealand
Rest of Asia Pacific

Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.


Read More@

Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
Market Segmentation
Estimated Market Sizing in terms of volume and value
Recent trends in Market and impact
Research Status and Technology Overview
Extensive Industry Structure Coverage


Contact Us


Name:  David

Email :

Phone: +1 313 462 0609

Acerca de Kenneth research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Mas información acerca de Kenneth research

  • Imprimir
  • Reportar abuso


Escribe tu comentario